Named Bioactive Compounds · Compound
Capsanthin
Moderate Evidencecarotenoid1 PubMed Study
Hermetica Superfood Encyclopedia
Capsanthin is a red carotenoid pigment primarily found in red peppers that exhibits anti-inflammatory and potential anticancer properties. This compound works by modulating cytokine production and cellular signaling pathways involved in inflammation and tumor growth.
Capsanthin is a red carotenoid pigment primarily synthesized in red pepper fruits (Capsicum annuum), particularly in paprika varieties, where it contributes to their characteristic color. It belongs to the xanthophyll subclass of carotenoids, featuring a unique κ-carotene structure with conjugated double bonds and hydroxyl groups. Extraction typically involves solvent-based methods from mature red pepper fruits.
No human clinical trials, randomized controlled trials, or meta-analyses on capsanthin were identified. All evidence is limited to preclinical studies, including in vitro cancer cell studies showing inhibited proliferation and G1/S phase arrest at 0.5-40 μM concentrations, and mouse studies (n=3 per group) demonstrating delayed tumor formation with 0.036-0.36 mg/kg doses (PMID: 33934088).
No clinically studied human dosages are available. Preclinical studies used 0.5-40 μM in cell cultures and 0.036-0.36 mg/kg intraperitoneally in mice. No standardized extract percentages have been established. Consult a healthcare provider before starting any new supplement.
Capsanthin is a naturally occurring carotenoid pigment (C40H56O3, molecular weight ~584.87 g/mol) primarily responsible for the red coloration in ripe red peppers (Capsicum annuum). It is classified as a xanthophyll ketocarotenoid. Key profile details: • Concentration in red bell peppers: approximately 1.5–6.0 mg/g dry weight, often constituting 30–60% of total carotenoid content in fully ripe red peppers. • In paprika oleoresin (a concentrated extract), capsanthin levels can reach 5–15 mg/g or higher depending on extraction and processing. • It is a lipophilic compound with poor water solubility; bioavailability is significantly enhanced when consumed with dietary fat (e.g., olive oil, avocado) — co-ingestion with lipids can increase absorption several-fold. • Unlike β-carotene, capsanthin has no provitamin A activity (it cannot be converted to retinol). • It possesses potent antioxidant capacity, with in vitro radical-scavenging activity reported to exceed that of β-carotene and lycopene in certain assays due to its conjugated polyene chain with a carbonyl group and hydroxyl group (11 conjugated double bonds plus keto functionality). • Capsanthin is often co-present with capsorubin (another red ketocarotenoid), β-carotene, β-cryptoxanthin, zeaxanthin, and violaxanthin in red pepper matrices. • Estimated dietary intake varies widely by population; in paprika-consuming cultures (e.g., Hungary, Spain, Korea), daily intake may reach 1–5 mg/day from food sources. • Absorption occurs via passive diffusion and facilitated transport (SR-BI, CD36 receptors) in intestinal enterocytes; it is incorporated into chylomicrons and transported via lipoproteins. Capsanthin has been detected in human serum and liver tissue, confirming systemic bioavailability, though plasma concentrations are typically low (nanomolar range) compared to more abundant dietary carotenoids like β-carotene or lycopene. • Thermal processing (cooking, roasting) of red peppers can improve capsanthin bioaccessibility by disrupting cell walls, though excessive heat or light exposure may cause cis-trans isomerization and partial degradation. • No established RDA or DRI exists for capsanthin specifically; it is not classified as an essential nutrient. • As an isolated compound it contains no macronutrients (protein, fat, carbohydrate, fiber), vitamins, or minerals — these are contributed by the food matrix (red peppers, paprika) in which it naturally occurs.
Capsanthin modulates inflammatory cytokine production by suppressing TNF-α, IL-2, IL-4, and IL-6 expression through NF-κB pathway inhibition. The compound also influences cellular proliferation by affecting apoptotic pathways and may enhance chemotherapy sensitivity in cancer cells. Additionally, capsanthin promotes cholesterol efflux, potentially supporting cardiovascular health through lipid metabolism regulation.
Current evidence for capsanthin is primarily from preclinical studies, with limited human clinical data available. Animal studies demonstrate significant reductions in inflammatory markers in dry eye models, with decreased cytokine levels observed. Cell culture studies show promising anticancer effects against triple-negative breast cancer cells, with enhanced chemotherapy sensitivity reported. Human clinical trials are needed to establish therapeutic dosages and confirm these preliminary findings in real-world applications.
Capsanthin appears to have a favorable safety profile as it is naturally consumed through red pepper intake in normal diets. No significant adverse effects have been reported in preclinical studies, though comprehensive human safety data is lacking. Potential interactions with chemotherapy drugs may exist given its reported ability to enhance drug sensitivity, requiring medical supervision if used therapeutically. Pregnancy and lactation safety has not been established through clinical studies, so caution is advised during these periods.
